about
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: Influenza life-cycle and currently available drugsAllele-specific suppression of mutant huntingtin using antisense oligonucleotides: providing a therapeutic option for all Huntington disease patientsCurrent Pharmacological Approaches to Reduce Chorea in Huntington's Disease.Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical PerformanceCurrent therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?Genomic Analysis Reveals Disruption of Striatal Neuronal Development and Therapeutic Targets in Human Huntington's Disease Neural Stem Cells.A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.
P2860
Q28085400-459D2437-2406-45F3-B7C0-7B5A9146C847Q28542911-D1EBFFDA-3850-4FFD-B6FB-F97EB6D8332AQ34547558-CB6C440F-45FF-4E70-9114-CBD9A645F0AEQ35906778-11F03ABE-E10D-4E26-BC57-078F0E46ADB0Q38244078-DBBDF8ED-7107-4B54-9B62-70884FFDA0D1Q38813105-82280084-5198-462E-9FBF-6E36531DDA64Q45288855-BF8C8B18-0561-4079-9AEF-6940CAD4B28B
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Treatment of huntington disease
@en
Treatment of huntington disease
@nl
type
label
Treatment of huntington disease
@en
Treatment of huntington disease
@nl
prefLabel
Treatment of huntington disease
@en
Treatment of huntington disease
@nl
P2860
P1476
Treatment of huntington disease
@en
P2093
Aleksandar Videnovic
P2860
P2888
P304
P356
10.1007/S11940-013-0219-8
P577
2013-08-01T00:00:00Z
P6179
1048698747